Healthcare Research, Analytics & Technology
See all in Find stocks →P/E
30.7×
ROCE
16.8%
Op. margin
8.6%
Sales growth 3Y
5.4%
Profit growth 3Y
14.7%
Share price 1Y
−29.0%
Companies
| Company | Market cap | P/E | ROCE | Op. margin | Sales growth 3Y | Share price 1Y |
|---|---|---|---|---|---|---|
| Syngene International | ₹16K Cr | 87.4× | 6.0% | 8.6% | 5.4% | −38.8% |
| Indegene | ₹14K Cr | 34.3× | 16.8% | 12.4% | 15.0% | +9.4% |
| Suven Life Sciences | ₹7K Cr | — | -59.5% | -4228.1% | -19.3% | +26.4% |
| Vimta Labs | ₹2K Cr | 27.0× | 21.6% | 23.2% | 8.9% | −29.0% |
| TAKE | ₹157.698 Cr | 12.3× | 42.4% | -2.1% | -34.1% | −53.1% |
Largest companies first. See every company in Find stocks →
Medians from the latest consolidated results (2026-11-01); share price change over the last year.